BioTheryX, Inc.   Report issue

For profit Phase 1
Founded: San Diego CA United States (2008)

Organization Overview

First Clinical Trial
2020
NCT04243785
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

BioTheryX, Inc.